Open AccessSchizophrenia
Author(s) -
Alkomiet Hasan,
Peter Falkai,
Isabell Lehmann,
Wolfgang Gäebel
Publication year - 2020
Publication title -
deutsches ärzteblatt international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.436
H-Index - 60
ISSN - 1866-0452
DOI - 10.3238/arztebl.2020.0412
Subject(s) - medicine , antipsychotic , guideline , schizophrenia (object oriented programming) , psychosocial , psychiatry , number needed to treat , quality of life (healthcare) , intensive care medicine , placebo , alternative medicine , nursing , pathology
The lifetime prevalence of schizophrenia is 1%. Schizophrenia is among the most severe mental illnesses and gives rise to the highest treatment costs per patient of any disease. It is characterized by frequent relapses, marked impairment of quality of life, and reduced social and work participation.